Establishment Labs Holdings (ESTA) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.96% |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 3.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.78% |
| Mar 31, 2026 | 9.38% |
| Dec 31, 2025 | 13.96% |
| Sep 30, 2025 | 24.81% |
| Jun 30, 2025 | 29.26% |
| Mar 31, 2025 | 48.56% |
| Dec 31, 2024 | 61.11% |
| Sep 30, 2024 | 67.90% |
| Jun 30, 2024 | 68.63% |
| Mar 31, 2024 | 69.33% |
| Dec 31, 2023 | 68.28% |
| Sep 30, 2023 | 64.69% |
| Mar 31, 2023 | 52.03% |
| Dec 31, 2022 | 46.00% |
| Sep 30, 2022 | 33.05% |
| Jun 30, 2022 | 28.39% |
| Mar 31, 2022 | 20.85% |
| Dec 31, 2021 | 13.05% |
| Sep 30, 2021 | 9.19% |
| Jun 30, 2021 | 7.81% |